First Time Loading...

DiaMedica Therapeutics Inc
NASDAQ:DMAC

Watchlist Manager
DiaMedica Therapeutics Inc Logo
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Watchlist
Price: 2.59 USD 2.37% Market Closed
Updated: May 2, 2024

DiaMedica Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DiaMedica Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Cash from Investing Activities
-$18.3m
CAGR 3-Years
-4%
CAGR 5-Years
-226%
CAGR 10-Years
-63%
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
-24%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is DiaMedica Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-18.3m USD

Based on the financial report for Dec 31, 2023, DiaMedica Therapeutics Inc's Cash from Investing Activities amounts to -18.3m USD.

What is DiaMedica Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-63%

The average annual Cash from Investing Activities growth rates for DiaMedica Therapeutics Inc have been -4% over the past three years , -226% over the past five years , and -63% over the past ten years .